GlaxoSmithKline v. Commission
European Union Court of Justice
Cases C-501/06 P, C-513/06 P, C-515/06 P and C 519/06 P, 2009 E.C.R. I-9291 (2009)
- Written by Kelli Lanski, JD
Facts
GlaxoSmithKline (GSK) (defendant) sold pharmaceutical products to Spanish wholesalers. GSK charged those wholesalers more if they resold outside of Spain than if they resold GSK’s products in Spain. GSK conceded that this pricing practice was intended to impede parallel trade, and the European Commission (commission) (plaintiff) held that GSK’s conduct violated Article 101 of the Treaty on the Functioning of the European Union (TFEU). The commission found that GSK’s conduct was a restriction by object; as a result, the commission did not need to prove anticompetitive effects. On appeal, the general court reversed, holding that GSK’s agreements were not restrictions by object and therefore the commission did need to prove anticompetitive effects. The commission appealed to the European Union Court of Justice.
Rule of Law
Issue
Holding and Reasoning ()
What to do next…
Here's why 812,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 46,300 briefs, keyed to 988 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.
